A Phase 1/2 interventional study of Tooth Bleaching with Whiteness HP Automixx 35% and Tooth Bleaching with Whiteness HP Automixx 6% in Sensitivity, Tooth, sponsored by University of Nove de Julho. Not yet recruiting. Open to participants aged 3 Years to 6 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-11-04.
Sponsored by University of Nove de Julho · Phase 1/2, Interventional, and Treatment
The aesthetics of dental elements generates great psychological and social impacts, both in the deciduous and permanent dentition. One of the techniques widely used to visually improve the appearance of teeth is bleaching. Bleaching can be performed both at home and in a dental office. In office whitening, the technique used consists of applying the whitening gel to the dental surfaces in concentrations ranging from 25% to 50% of hydrogen peroxide. However, recent studies show that low and medium concentration bleaching agents based on hydrogen peroxide have been effective and present a lower risk of sensitivity to the patient. In view of the above, this study aims to carry out a controlled and randomized clinical trial to compare the effectiveness of dental bleaching in deciduous teeth with hydrogen peroxide at concentrations of 35% and 6%. For this, 38 patients aged 03 to 06 years will be selected, allocated in 2 groups (G1 - Hydrogen Peroxide 35%, n=19 and G2- Hydrogen Peroxide 6%, n=19). Bleaching will be carried out in up to three sessions, with an interval of 7 days between them and the evaluation of color and tooth sensitivity will be carried out 48 hours after each bleaching session. The color assessment will be measured using a digital spectrometer and tooth sensitivity using the Pain Level Scale (Wong-Baker Faces®). Descriptive statistical analysis will be carried out, containing the mean and standard deviation in the calculation and normality and homogeneity tests will be carried out, for subsequent adequate statistical analysis. As a result, it is expected that there is no significant difference between the groups in terms of color variation and that the low-concentration bleaching group has the lowest sensitivity index.
288 studies on the registry are indexed under Dentin Sensitivity; 46 are open to participants now.
This study's planned enrollment of 38 is below the median of 60 across 279 interventional studies indexed under Dentin Sensitivity.
Browse Dentin Sensitivity studies →University of Nove de Julho is the lead sponsor of 246 studies on the registry; 52 are open to participants now.
Of its 8 completed or terminated interventional studies of FDA-regulated products, 1 (13%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
In the participants of this group, the tooth whitening process will be performed with 35% hydrogen peroxide.
Procedure: Tooth Bleaching with Whiteness HP Automixx 35%
In the participants of this group, the tooth whitening process will be performed with 6% hydrogen peroxide.
Procedure: Tooth Bleaching with Whiteness HP Automixx 6%
* Clinical examination and taking the initial shade of the tooth with Vita Easyshade®; * Sensitivity/pain recording using the Pain Level Scale (Wong-Baker Faces®); * Prophylaxis with a Robson brush and prophylactic paste; * Application of lip balm on the patient's lips; * Placement of the labial retractor; * Application of the gingival barrier; * Application of Whiteness HP Automixx 35% whitening gel; * In the session, a single application of the gel will be carried out and where it will remain on the surface of the tooth for 15 min; * The gel must be removed from the teeth with a sucker and the teeth cleaned with gauze; * Sensitivity/pain recording using the Pain Level Scale (Wong-Baker Faces®); * The second bleaching session will be carried out 7 days after the first one and, if necessary, a third session can be carried out 7 days after the second one.
* Clinical examination and taking the initial shade of the tooth with Vita Easyshade®; * Sensitivity/pain recording using the Pain Level Scale (Wong-Baker Faces®); * Prophylaxis with a Robson brush and prophylactic paste; * Application of lip balm on the patient's lips; * Placement of the labial retractor; * Application of the gingival barrier; * Application of Whiteness HP Automixx 6% whitening gel; * In the session, a single application of the gel will be carried out and where it will remain on the surface of the tooth for 15 min; * The gel must be removed from the teeth with a sucker and the teeth cleaned with gauze; * Sensitivity/pain recording using the Pain Level Scale (Wong-Baker Faces®); * The second bleaching session will be carried out 7 days after the first one and, if necessary, a third session can be carried out 7 days after the second one.
Changes in tooth color
The Vita Easyshade® digital spectrometer (VITA Zahnfabrik H. Rauter GmbH \& Co. KG, Germany) will be used for evaluation. The upper left canine will be used as a color reference because it is the most saturated tooth in the arch (greater dentin mass and greater amount of intrinsic pigments).
Time frame: Baseline and 48 hours after each bleaching session.
Changes in tooth sensitivity
It will be explained to the participant that each face drawn in a figure represents a person who has no pain, or some, or a lot of pain. Face 0 doesn't hurt at all. Face 2 hurts a little. Face 4 hurts a little more. Face 6 hurts a lot. Face 8 hurts the most. Face 10 hurts as much as you can imagine, although you don't have to be crying to have this worst pain. The participant will choose the face that best portrays the pain they are experiencing.
Time frame: Baseline and 48 hours after each bleaching session.
No study locations are listed for this record.
This study is not yet recruiting, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.